UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063714
Receipt number R000072911
Scientific Title A Nationwide Survey on Postoperative Bowel Function in Pediatric Patients with Anorectal Malformations and Hirschsprung's Disease in Japan
Date of disclosure of the study information 2026/11/20
Last modified on 2026/11/20 22:08:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Nationwide Survey on Postoperative Bowel Function in Children with Anorectal Malformations and Hirschsprung's Disease in Japan

Acronym

Nationwide Survey on Pediatric Bowel Function (Anorectal Malformations and Hirschsprung's Disease)

Scientific Title

A Nationwide Survey on Postoperative Bowel Function in Pediatric Patients with Anorectal Malformations and Hirschsprung's Disease in Japan

Scientific Title:Acronym

Nationwide Survey on Postoperative Bowel Function in ARM and HD

Region

Japan


Condition

Condition

Anorectal Malformations and Hirschsprung's Disease

Classification by specialty

Gastrointestinal surgery Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To comprehensively elucidate the mid- to long-term postoperative status of bowel function and fecal incontinence in patients with anorectal malformations (ARM) and Hirschsprung's disease (HD), and to establish a clinical evaluation framework for the development of novel therapeutic medical devices.

Basic objectives2

Others

Basic objectives -Others

In this nationwide multicenter observational study, postoperative bowel function in pediatric patients will be quantitatively evaluated using prospective bowel diaries, clinical bowel function scores, and quality-of-life scales (PedsQL), comparing outcomes with healthy controls and analyzing associations with underlying diseases, subtypes, and surgical procedures.

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Comparison of the number of days with fecal incontinence per week by underlying disease and disease subtype

Key secondary outcomes

1. Number of days with bowel movements per week by underlying disease and disease subtype
2. Bowel function scores assessed by various evaluation scales by underlying disease and disease subtype
3. Association between diagnosis/disease subtype and weekly frequencies of bowel movements and fecal incontinence
4. Association between surgical procedure and weekly frequencies of bowel movements and fecal incontinence
5. Association of weekly frequencies of bowel movements and fecal incontinence with clinical bowel function scores
6. Association of weekly frequencies of bowel movements and fecal incontinence with quality of life (QOL)
7. Changes in clinical bowel function scores and quality of life (QOL) before and after keeping a bowel diary


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

5 years-old <=

Age-upper limit

16 years-old >

Gender

Male and Female

Key inclusion criteria

Patient Group:
Patients who have undergone surgery for anorectal malformations (ARM) or Hirschsprung's disease (HD) and are visiting as outpatients or admitted as inpatients at institutional member hospitals of the Japanese Study Group for Anorectal Malformations (63 participating institutions) between the date of institutional approval and December 31, 2028.

Control Group:
Individuals with no history of ARM, HD, constipation, or fecal incontinence.

Inclusion Criteria:
1. Aged 5 years or older and under 16 years at the time of informed consent.
2. For postoperative ARM patients, those who have undergone anoplasty and are registered in the database of the Japanese Study Group for Anorectal Malformations (database registration is not required for postoperative HD patients).
3. Patients who are receiving ongoing medical follow-up.
4. Individuals (and/or their legally authorized representatives/proxies) who have provided written informed consent of their own free will after receiving and fully understanding a thorough explanation of the study.

Key exclusion criteria

1. Individuals who currently have a stoma (colostomy or ileostomy).
2. Individuals with diseases other than anorectal malformations (ARM) that cause bowel dysfunction (e.g., spina bifida).
3. Individuals participating in the specified clinical trial titled "A Multicenter, Open-Label, Single-Arm Specified Clinical Trial on the Validation of Anal Function Evaluation Indices Using a Simultaneous Electromyography and Manometry Device and Exploratory Evaluation of a Home-Based Anal Function Training Model in Postoperative Patients with Anorectal Malformations and Hirschsprung's Disease."
4. Any other individuals deemed inappropriate for study participation by the Principal Investigator.

Target sample size

330


Research contact person

Name of lead principal investigator

1st name Momoko
Middle name
Last name Ara

Organization

Hokkaido University Graduate School of Medicine

Division name

Department of Gastroenterological Surgery I

Zip code

060-8638

Address

Kita 15-jo Nishi 7-chome, Kita-ku, Sapporo, Hokkaido 060-8638, Japan

TEL

011-706-5927

Email

aramomoko@huhp.hokudai.ac.jp


Public contact

Name of contact person

1st name Momoko
Middle name
Last name Ara

Organization

Hokkaido University Graduate School of Medicine

Division name

Department of Gastroenterological Surgery I

Zip code

060-8638

Address

Kita 15-jo Nishi 7-chome, Kita-ku, Sapporo, Hokkaido 060-8638, Japan

TEL

011-706-5927

Homepage URL


Email

aramomoko@huhp.hokudai.ac.jp


Sponsor or person

Institute

Hokkaido University

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Review Board for Life Science and Medical Research, Hokkaido University Hospital

Address

Kita 14-jo Nishi 5-chome, Kita-ku, Sapporo

Tel

011-706-7636

Email

crjimu@huhp.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2026 Year 08 Month 17 Day

Date of IRB

2026 Year 09 Month 03 Day

Anticipated trial start date

2026 Year 11 Month 09 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This is an observational study with no therapeutic intervention. Participants (patients and their parents/guardians) complete questionnaires on bowel function and quality of life (QOL) once before and once after a 2-week bowel diary recording period, and record daily bowel movements and fecal incontinence episodes in a prospective bowel diary for 14 consecutive days (2 weeks).


Management information

Registered date

2026 Year 11 Month 20 Day

Last modified on

2026 Year 11 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072911